Cognito Therapeutics
PrivateLast Round
Series C
Mar 5, 2026
Total Funding Raised
$419.2M
Momentum Score
50 /100
Company Overview
Cognito Therapeutics is a digital health company that develops disease-modifying therapies aimed at treating neurodegenerative disorders by utilizing induced brain wave oscillations to reactivate the brain's immune system and reduce key Alzheimer's disease markers such as amyloid plaques and tau tangles.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials, Biotechnology, Health IoT
Business Model
B2B2C
Customer Profile
Hardware + Subscription, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cognito Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Cognito Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Mar 5, 2026 | ||||
| Series C | Apr 1, 2025 | ||||
| Series B | Jul 2, 2024 | ||||
| Series B Extension | Feb 1, 2024 | ||||
| Series B | Mar 22, 2023 |
Key People
Founding team and executive leadership
Cognito Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| New Vintage Partners | Series C |
| IAG Capital Partners | Series B, Series C |
| Starbloom Capital | Series B, Series B Extension, Series C |
| FoundersX Ventures | Series B Extension, Series B |
| Morningside Ventures | Series B, Series C, Series A |
| WS Investment Company | Series B |
| Alzheimer's Drug Discovery Foundation | Series B, Series B Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 1, 2026
Topline data from the HOPE pivotal study anticipated in summer 2026.
- Apr 7, 2026
Translating scientific findings from MIT into therapeutic approaches.
Cognito Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Cognito Therapeutics's valuation, stock price, and market status.
